| 000 | 01071 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518005357.0 | ||
| 264 | 0 | _c20190830 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0000000000002008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNyanhete, Tinashe | |
| 245 | 0 | 0 |
_aCD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _c11 2018 |
||
| 300 |
_a2835-2838 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Comment | ||
| 650 | 0 | 4 | _aCD8-Positive T-Lymphocytes |
| 650 | 0 | 4 | _aEukaryotic Initiation Factor-2 |
| 650 | 0 | 4 | _aHIV Infections |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolic Networks and Pathways |
| 650 | 0 | 4 | _aSirolimus |
| 700 | 1 | _aTomaras, Georgia D | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 32 _gno. 18 _gp. 2835-2838 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0000000000002008 _zAvailable from publisher's website |
| 999 |
_c29023125 _d29023125 |
||